This inventor holds 2 USPTO granted patents. Top assignee: Bayer Aktiengesellschaft. Active years: 1993-1999.
Location History:
- Bergisch Gladbach, DE (1993)
- Bergish Gladbach, DE (1999)
Company Filing History:
Years Active: 1993-1999
Title: Franz Hausler: Innovator in Pharmaceutical Formulations
Introduction
Franz Hausler is a notable inventor based in Bergisch Gladbach, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative chewing gum formulations. With a total of 2 patents, his work has the potential to enhance the delivery of active compounds in a convenient format.
Latest Patents
Hausler's latest patents include a pharmaceutical chewing gum containing acetylsalicylic acid. This invention relates to stable, pharmaceutically usable chewing gum formulations that incorporate acetylsalicylic acid (ASA) as the active compound, along with a process for their preparation. Another significant patent is for an antacid preparation having a prolonged gastric residence time. This invention comprises an antacid active substance, calcium polycarbophil, and a water-insoluble, anionic polymer, aimed at improving the effectiveness of antacid treatments.
Career Highlights
Franz Hausler is associated with Bayer Aktiengesellschaft, a leading global company in the pharmaceutical and life sciences sector. His work at Bayer has allowed him to focus on innovative solutions that address common health issues through novel delivery methods.
Collaborations
Throughout his career, Hausler has collaborated with esteemed colleagues such as Christian Fritsch and Jurgen Seedig. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in pharmaceutical development.
Conclusion
Franz Hausler's contributions to pharmaceutical innovations, particularly in chewing gum formulations, highlight his role as a forward-thinking inventor. His patents reflect a commitment to improving health solutions through creative and effective delivery methods.